BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 28260869)

  • 1. Efficacy and safety of short- and long-term, regular and on-demand regimens of phosphodiesterase type 5 inhibitors in treating erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.
    Tian D; Wang XY; Zong HT; Zhang Y
    Clin Interv Aging; 2017; 12():405-412. PubMed ID: 28260869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT).
    Mulhall JP; Brock G; Oelke M; Fode M; Probst KA; Henneges C; d'Anzeo G; Rossi A; Büttner H
    J Sex Med; 2016 Apr; 13(4):679-83. PubMed ID: 27045264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Cui Y; Liu X; Shi L; Gao Z
    Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy.
    Moncada I; de Bethencourt FR; Lledó-García E; Romero-Otero J; Turbi C; Büttner H; Henneges C; Martinez Salamanca JI
    World J Urol; 2015 Jul; 33(7):1031-8. PubMed ID: 25155034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy.
    Wang X; Wang X; Liu T; He Q; Wang Y; Zhang X
    PLoS One; 2014; 9(3):e91327. PubMed ID: 24618671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.
    Goh HJ; Sung JM; Lee KH; Jo JK; Kim KN
    Transl Androl Urol; 2022 Feb; 11(2):124-138. PubMed ID: 35280664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
    Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
    BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the dose of vardenafil on a daily basis does not improve erectile function after unilateral nerve-sparing radical prostatectomy.
    Bannowsky A; van Ahlen H; Loch T
    J Sex Med; 2012 May; 9(5):1448-53. PubMed ID: 22462626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment effects of phosphodiesterase-5 inhibitors may improve with time following nerve-sparing radical prostatectomy.
    Fode M; Østergren PB; Jensen CFS; Jakobsen H; Sønksen J
    Scand J Urol; 2018 Apr; 52(2):108-110. PubMed ID: 29057723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
    Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
    BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile function outcome after bilateral nerve sparing radical prostatectomy: which patients may be left untreated?
    Gallina A; Ferrari M; Suardi N; Capitanio U; Abdollah F; Tutolo M; Bianchi M; Saccà A; Salonia A; Rigatti P; Montorsi F; Briganti A
    J Sex Med; 2012 Mar; 9(3):903-8. PubMed ID: 22240189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis.
    Limoncin E; Gravina GL; Corona G; Maggi M; Ciocca G; Lenzi A; Jannini EA
    Andrology; 2017 Sep; 5(5):863-872. PubMed ID: 28787547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy.
    Montorsi F; Brock G; Lee J; Shapiro J; Van Poppel H; Graefen M; Stief C
    Eur Urol; 2008 Oct; 54(4):924-31. PubMed ID: 18640769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penile rehabilitation for postprostatectomy erectile dysfunction.
    Philippou YA; Jung JH; Steggall MJ; O'Driscoll ST; Bakker CJ; Bodie JA; Dahm P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012414. PubMed ID: 30352488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer.
    Qiu S; Tang Z; Deng L; Liu L; Han P; Yang L; Wei Q
    Sci Rep; 2016 Sep; 6():32853. PubMed ID: 27611008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase type 5 inhibitors for the treatment of post-nerve sparing radical prostatectomy erectile dysfunction in men.
    Li J; Shi Q; Pu C; Tang Y; Bai Y; Yuan H; Li X; Dong Q; Wei Q; Yuan J; Han P
    Sci Rep; 2014 Jul; 4():5801. PubMed ID: 25052550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management strategy of treating patients with erectile dysfunction after radical prostatectomy: a systematic review and meta-analysis.
    Feng D; Tang C; Liu S; Yang Y; Han P; Wei W
    Int J Impot Res; 2022 Jan; 34(1):18-36. PubMed ID: 33099581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo.
    Stolzenburg JU; Graefen M; Kriegel C; Michl U; Martin Morales A; Pommerville PJ; Manning M; Büttner H; Henneges C; Schostak M
    BJU Int; 2015 Aug; 116(2):241-51. PubMed ID: 25560809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.